He will oversee the company’s psychiatry and mental wellness strategy. Dr. Lieberman will also focus on expanding personalized anxiety and depression treatments.
Prior to joining Hims & Hers, he served as a clinical professor of psychiatry and behavioral sciences at George Washington (D.C.) University. He has advised the Department of Commerce and the Office of Drug & Alcohol Policy & Compliance on psychiatric topics.
Hims & Hers Health surpassed 1 million subscribers and reported $527 million in revenue in Q4 2022, a 94 percent year-over-year increase.
